Overview

A 12 Week Study of MK0653A in Patients Who Have Been Hospitalized for a Possible Heart Problem (0653A-808)

Status:
Completed

Trial end date:
2007-06-01

Target enrollment:
0

Participant gender:
All

Summary

The purpose of this study is to investigate the effect of an investigational cholesterol-lowering drug in patients who are currently taking an approved medication for hypercholesterolemia (high cholesterol levels) and have been hospitalized for a heart problem.

Phase:

Phase 3

Accepts Healthy Volunteers?

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.

Treatments:

Atorvastatin
Atorvastatin Calcium
Dihydromevinolin
Ezetimibe
Fluvastatin
L 647318
Lovastatin
Pravastatin
Rosuvastatin Calcium
Simvastatin

Criteria

Inclusion Criteria:

- Patients greater than 18 years old, who were admitted to a hospital for an
investigation of a heart problem and are currently receiving an approved medication to
lower cholesterol

Exclusion Criteria:

- Patients who have congestive heart failure (CHF), uncontrolled high blood pressure,
poorly controlled blood sugar, impaired kidney function, or HIV.